9-October-2019: The global nephrostomy
devices market size is anticipated to reach USD 1.71
billion by 2026 registering a CAGR of 7.8%, according to a new report by Grand
View Research, Inc. Increasing awareness about nephrostomy devices among
physicians and rising cases of kidney stone disease are driving the market.
Increasing prevalence of ovarian, bladder, and prostate cancers and improving
healthcare infrastructure in the developing economies are also among the key
factors fueling the market growth.
North America is expected
to register the highest market share owing to increasing prevalence of kidney
stone disorder and ovarian, bladder, and prostate cancers. For instance,
according to the American Cancer Society, around 22,240 new cases of ovarian
cancer were diagnosed in 2018 in U.S. Major companies in this market are
emphasizing on new product launches and innovations in the existing products.
For instance, in February 2017, Cook Medical introduced Universa along with the
two sets of percutaneous urinary drainage.
In
depth research report on Nephrostomy Devices Market
Further key findings from the study suggest:
·
Guidewires segment led the global nephrostomy devices market
in 2018 and is anticipated to expand further at the highest CAGR from 2019 to
2026
·
The segment growth is attributed to rising cases of kidney
and urine related disorders, and preference for guidewires as they are less
invasive
·
The hospital segment dominated the market in 2018.
Percutaneous nephrostomy are majorly performed in the hospitals as compared to
the emergency clinics, which drives the segment growth
·
ASCs segment is anticipated to register the highest CAGR as
nephrostomy devices are widely used by ASCs due to their benefits, such as
significant cost saving and personalized services
·
North America leads the market due to high prevalence of
target diseases, availability of skilled surgeons, presence of well-established
healthcare sector, and quick adoption of advanced medical tools
·
Key companies in the market focus on strategies, such as
innovations in the existing products, introduction of new products, and mergers
and acquisitions to strengthen their presence in the industry
Grand View Research
has segmented the global nephrostomy devices market on the basis of product,
end use, and region:
Nephrostomy Devices Product Outlook (Revenue, USD Million,
2015 - 2026)
·
Guidewires
·
Drainage Tubes
·
Nephrostomy Catheters
·
Sheath Dilators
·
Others
Nephrostomy Devices End Use Outlook (Revenue, USD Million,
2015 - 2026)
·
Hospitals
·
Emergency Clinics
·
Ambulatory Surgical Centers (ASCs)
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is the
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment